1. Home
  2. NRSN vs ZTG Comparison

NRSN vs ZTG Comparison

Compare NRSN & ZTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.69

Market Cap

25.5M

Sector

Health Care

ML Signal

HOLD

ZTG

Zenta Group Company Limited Class A Ordinary Shares

N/A

Current Price

$1.91

Market Cap

20.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
NRSN
ZTG
Founded
2017
N/A
Country
Israel
Macau
Employees
16
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
25.5M
20.4M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
NRSN
ZTG
Price
$0.69
$1.91
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
215.7K
102.7K
Earning Date
03-31-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$583.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$1.46
52 Week High
$2.18
$2.39

Technical Indicators

Market Signals
Indicator
NRSN
ZTG
Relative Strength Index (RSI) 38.64 65.28
Support Level $0.68 $1.46
Resistance Level $0.75 N/A
Average True Range (ATR) 0.08 0.28
MACD -0.00 0.02
Stochastic Oscillator 8.47 58.06

Price Performance

Historical Comparison
NRSN
ZTG

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: